Chief Investor Counsel Rosen encourages Bluebird Bio investors to inquire about securities class action investigation 'BLUE'



New York, April 27, 2024 (GLOBE NEWSWIRE) —

Why: Rosen Law Firm, a global investor rights law firm, continues to represent shareholders of Bluebird Biologics, Inc. (NASDAQ: BLUE) in its investigation of potential securities claims arising from Bluebird’s possible release of materially misleading business information to the investing public. .

so what: If you purchased Bluebird securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. Rosen Law Firm is preparing to file a class action lawsuit seeking to recover investor losses.

What to do next: To join the anticipated class action, please visit https://rosenlegal.com/submit-form/?case_id=23843 or call Mr. Phillip Kim. For information about the class action lawsuit, call toll-free 866-767-3653 or email case@rosenlegal.com.

What is it about: On March 26, 2024, before the market opened, Bluebird submitted an 8-K to the SEC, which announced: [o]On March 24, 2024, the Audit Committee of the company's board of directors (hereinafter referred to as the “Audit Committee”), based on the management's recommendations and consultation with Ernst & Young, concluded that the company's previously audited consolidated financial statements for each fiscal year since 2019 The financial statements beginning January 1 and its previously released unaudited interim condensed consolidated financial statements for the first three quarters, as well as related earnings releases and investor presentations or other communications describing such financial statements, contain material errors Statements, therefore, should no longer be relied upon.

Affected by this news, Bluebird's stock price fell by US$0.16 per share, or 11.8%, on March 26, 2024, to close at US$1.20 per share.

3rd party advertising. Not an offer or recommendation by Investing.com.See disclosures here or
Remove ads
.

Why Choose Rosen Method: Investors are encouraged to select qualified counsel with a track record of success in leadership roles. Often, companies issuing notices do not have similar experience, resources, or any meaningful peer recognition. Many of these companies do not actually file securities class action lawsuits. Choose your advisor wisely. Rosen Law Firm represents investors worldwide and focuses its practice on securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese company. Rosen Law Firm ranks No. 1 in ISS Securities Class Action Services' 2017 rankings for number of securities class action settlements. In 2019 alone, the company raised more than $438 million from investors. In 2020, founding partner Laurence Rosen was named a “Plaintiffs Bar Titan” by law360. Many of our lawyers have been recognized by Lawdragon and Super Lawyers.

Follow us on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook (NASDAQ:) On: https://www.facebook.com/rosenlawfirm/.

Lawyer advertising. Previous results do not guarantee similar results.

Contact information:

Mr. Lawrence Rosen
Mr Philip King
Rosen Law Firm, Pennsylvania
275 Madison Avenue, 40th Floor
New York, NY 10016
Phone: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
case@rosenlegal.com
www.rosenlegal.com

3rd party advertising. Not an offer or recommendation by Investing.com.See disclosures here or
Remove ads
.





Source link

Leave a Reply

Your email address will not be published. Required fields are marked *